<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
 <url>
  <loc>https://www.dottnet.it/articolo/32543825/tumore-al-seno-50-anni-di-rivoluzione-nelle-cure-oggi-fino-al-40-dei-casi-puo-essere-evitato</loc>
  <lastmod>2026-09-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Tumore al seno, 50 anni di rivoluzione nelle cure: oggi fino al 40% dei casi può essere evitato</news:title>
   <news:publication_date>2026-09-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543825-anteprimearticolidottnet-2026-09-23t093509581.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543826/artrite-l-ecografia-cambia-le-regole-della-diagnosi-precoce-identificare-la-malattia-sara-piu-semplice</loc>
  <lastmod>2026-09-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Artrite, l’ecografia cambia le regole della diagnosi precoce: identificare la malattia sarà più semplice</news:title>
   <news:publication_date>2026-09-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543826-anteprimearticolidottnet-2026-09-23t100348077.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543828/pensioni-enpam-a-novembre-aumenti-e-dieci-mesi-di-arretrati</loc>
  <lastmod>2026-09-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Pensioni Enpam, a novembre aumenti e dieci mesi di arretrati</news:title>
   <news:publication_date>2026-09-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543828-pensioni.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543830/endometriosi-linzagolix-diventa-rimborsabile-la-terapia-punta-su-dolore-e-qualita-di-vita</loc>
  <lastmod>2026-09-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Endometriosi, linzagolix diventa rimborsabile: la terapia punta su dolore e qualità di vita</news:title>
   <news:publication_date>2026-09-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543830-anteprimearticolidottnet-2026-09-23t104517470.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543831/ipercolesterolemia-via-libera-europeo-a-obicetrapib-arrivano-ubeslo-ed-evlarco</loc>
  <lastmod>2026-09-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Ipercolesterolemia, via libera europeo a obicetrapib: arrivano Ubeslo ed Evlarco</news:title>
   <news:publication_date>2026-09-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543831-doctor-s-table-with-medicaments-medical-supplies-blue-folder.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543832/novo-nordisk-cagrisema-riduce-il-peso-del-21-nell-obesita-e-mostra-forte-efficacia-nel-diabete-tipo-2</loc>
  <lastmod>2026-09-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Novo Nordisk: CagriSema riduce il peso del 21% nell&#39;obesità e mostra forte efficacia nel diabete tipo 2</news:title>
   <news:publication_date>2026-09-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543832-wavymed-08single-10.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543833/brufeact-aggiornata-la-scheda-tecnica-inserita-l-eruzione-fissa-da-farmaci-tra-le-reazioni-avverse</loc>
  <lastmod>2026-09-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Brufeact, aggiornata la scheda tecnica: inserita l&#39;eruzione fissa da farmaci tra le reazioni avverse</news:title>
   <news:publication_date>2026-09-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543833-top-view-world-heart-day-with-pills1.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543744/mhra-aggiorna-le-avvertenze-in-etichetta-focus-su-oppioidi-paracetamolo-e-farmaci-ad-alto-rischio</loc>
  <lastmod>2026-09-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>MHRA aggiorna le avvertenze in etichetta: focus su oppioidi, paracetamolo e farmaci ad alto rischio</news:title>
   <news:publication_date>2026-09-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543744-tinydepressedwomanwithanxietysittingonlargepill.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543836/covid-19-l-ue-autorizza-ensitrelvir-per-la-profilassi-dopo-l-esposizione</loc>
  <lastmod>2026-09-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>COVID-19, l’UE autorizza ensitrelvir per la profilassi dopo l’esposizione</news:title>
   <news:publication_date>2026-09-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543836-immaginecoronavirus.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543835/lea-essere-promossi-non-basta-le-cure-devono-essere-accessibili</loc>
  <lastmod>2026-09-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>LEA, essere promossi non basta: le cure devono essere accessibili</news:title>
   <news:publication_date>2026-09-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543835-cartabellotta.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543827/medici-di-famiglia-smi-porta-la-protesta-alla-camera-discutere-la-petizione-</loc>
  <lastmod>2026-09-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Medici di famiglia, SMI porta la protesta alla Camera: &#34;Discutere la petizione&#34;</news:title>
   <news:publication_date>2026-09-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543827-petizione2.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543829/morbillo-il-93-percento-dei-casi-nei-non-vaccinati-il-ministero-chiama-mmg-e-pediatri</loc>
  <lastmod>2026-09-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Morbillo, il 93 percento dei casi nei non vaccinati: il Ministero chiama MMG e pediatri</news:title>
   <news:publication_date>2026-09-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543829-vaccinazioni.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543837/dolore-neuropatico-orofacciale-rtms-e-tdcs-mostrano-risultati-promettenti</loc>
  <lastmod>2026-09-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Dolore neuropatico orofacciale, rTMS e tDCS mostrano risultati promettenti</news:title>
   <news:publication_date>2026-09-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543837-djvmar972-09.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543840/brain-health-dalla-prevenzione-alla-presa-in-carico-integrata-del-paziente-neurologico-</loc>
  <lastmod>2026-09-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Brain Health: dalla prevenzione alla presa in carico integrata del paziente neurologico.</news:title>
   <news:publication_date>2026-09-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543840-img3.jpeg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543838/malattie-neurodegenerative-e-nuovi-target-molecolari-verso-terapie-in-grado-di-modificare-il-decorso-della-malattia-</loc>
  <lastmod>2026-09-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Malattie neurodegenerative e nuovi target molecolari: verso terapie in grado di modificare il decorso della malattia.</news:title>
   <news:publication_date>2026-09-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543838-img1.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543839/biomarcatori-digitali-e-intelligenza-artificiale-nuove-frontiere-per-diagnosi-e-monitoraggio-in-neurologia-</loc>
  <lastmod>2026-09-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Biomarcatori digitali e intelligenza artificiale: nuove frontiere per diagnosi e monitoraggio in neurologia.</news:title>
   <news:publication_date>2026-09-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543839-img2.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543841/oltre-i-sintomi-il-ruolo-dei-biomarcatori-nella-diagnosi-precoce-delle-malattie-neurodegenerative-</loc>
  <lastmod>2026-09-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Oltre i sintomi: il ruolo dei biomarcatori nella diagnosi precoce delle malattie neurodegenerative.</news:title>
   <news:publication_date>2026-09-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543841-libro1.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543842/l-asse-immunitario-cervello-come-bersaglio-terapeutico-nelle-malattie-neurodegenerative-</loc>
  <lastmod>2026-09-23T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>L&#39;asse immunitario-cervello come bersaglio terapeutico nelle malattie neurodegenerative.</news:title>
   <news:publication_date>2026-09-23</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543842-libro2.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543843/il-senso-delle-parole-il-maxi-cruciverba-che-porta-l-oncologia-negli-ospedali-italiani</loc>
  <lastmod>2026-09-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>&#34;Il senso delle parole&#34;: il maxi-cruciverba che porta l&#39;oncologia negli ospedali italiani</news:title>
   <news:publication_date>2026-09-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543843-anteprimearticolidottnet-2026-09-24t085208800.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543791/congresso-sin-2026-a-bari-la-neonatologia-integra-innovazione-reti-e-cura-della-famiglia</loc>
  <lastmod>2026-09-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Congresso SIN 2026: a Bari la neonatologia integra innovazione, reti e cura della famiglia</news:title>
   <news:publication_date>2026-09-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543791-newborn-baby.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543746/vaccino-contro-l-herpes-zoster-possibile-beneficio-cardiovascolare</loc>
  <lastmod>2026-09-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Vaccino contro l’herpes zoster, possibile beneficio cardiovascolare</news:title>
   <news:publication_date>2026-09-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543746-19198640.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543778/topi-con-corteccia-umana-trapiantata-aprono-nuove-strade-per-lo-studio-delle-malattie-neurologiche</loc>
  <lastmod>2026-09-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Topi con corteccia umana trapiantata aprono nuove strade per lo studio delle malattie neurologiche</news:title>
   <news:publication_date>2026-09-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543778-magnificinserisci-un-topino-da-laboratorio22073.jpeg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543844/sedentari-e-in-eccesso-di-peso-la-sfida-e-rendere-la-salute-una-scelta-possibile</loc>
  <lastmod>2026-09-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Sedentari e in eccesso di peso: la sfida è rendere la salute una scelta possibile</news:title>
   <news:publication_date>2026-09-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543844-anteprimearticolidottnet-2026-09-24t095706184.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543845/medicina-rigenerativa-il-tessuto-adiposo-diventa-una-risorsa-terapeutica</loc>
  <lastmod>2026-09-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Medicina rigenerativa, il tessuto adiposo diventa una risorsa terapeutica</news:title>
   <news:publication_date>2026-09-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543845-face-treatment-concept.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543846/antibiotici-l-ue-stringe-sull-appropriatezza-dosi-legate-alla-terapia-e-piu-spazio-ai-test-diagnostici</loc>
  <lastmod>2026-09-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Antibiotici, l&#39;Ue stringe sull&#39;appropriatezza: dosi legate alla terapia e più spazio ai test diagnostici</news:title>
   <news:publication_date>2026-09-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543846-antibiotici.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543847/salute-maschile-arriva-il-decalogo-degli-urologi-per-vivere-piu-a-lungo</loc>
  <lastmod>2026-09-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Salute maschile, arriva il decalogo degli urologi per vivere più a lungo</news:title>
   <news:publication_date>2026-09-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543847-anteprimearticolidottnet-2026-09-24t102056354.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543848/farmaci-il-foglietto-illustrativo-diventa-digitale-ma-la-carta-non-scompare</loc>
  <lastmod>2026-09-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Farmaci, il foglietto illustrativo diventa digitale: ma la carta non scompare</news:title>
   <news:publication_date>2026-09-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543848-fogliettoillustrativo2.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543849/diagnostica-negli-studi-dei-medici-di-famiglia-cambiano-i-fondi-cosa-prevede-il-nuovo-decreto</loc>
  <lastmod>2026-09-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Diagnostica negli studi dei medici di famiglia, cambiano i fondi: cosa prevede il nuovo decreto</news:title>
   <news:publication_date>2026-09-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543849-strumentidiagnostici.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543851/sindrome-di-wiskott-aldrich-la-terapia-genica-conferma-benefici-a-lungo-termine</loc>
  <lastmod>2026-09-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Sindrome di Wiskott-Aldrich, la terapia genica conferma benefici a lungo termine</news:title>
   <news:publication_date>2026-09-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543851-dna.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543727/tumore-del-polmone-ros1-positivo-zidesamtinib-mostra-risposte-nel-94-dei-pazienti-naive-ai-tki</loc>
  <lastmod>2026-09-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Tumore del polmone ROS1-positivo, zidesamtinib mostra risposte nel 94% dei pazienti naïve ai TKI</news:title>
   <news:publication_date>2026-09-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543727-wavymed-06single-09.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543834/nifedipina-in-gocce-orali-salativ-20-mg-ml</loc>
  <lastmod>2026-09-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Nifedipina in gocce orali: SALATIV® 20 mg/mL</news:title>
   <news:publication_date>2026-09-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543834-salativ.png</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543850/asma-via-libera-ue-alla-triplice-terapia-in-un-unico-inalatore</loc>
  <lastmod>2026-09-24T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Asma, via libera UE alla triplice terapia in un unico inalatore</news:title>
   <news:publication_date>2026-09-24</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543850-portrait-boy-using-asthma-inhaler-treat-inflammatory-diseases-shortness-breath-concept-treatment-cough-allergies-respiratory-tract-disease.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543852/aifa-approva-9-nuove-rimborsabilita-mirdametinib-e-zanidatamab-per-malattie-rare-sette-estensioni-di-indicazione</loc>
  <lastmod>2026-09-25T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>AIFA approva 9 nuove rimborsabilità: mirdametinib e zanidatamab per malattie rare, sette estensioni di indicazione</news:title>
   <news:publication_date>2026-09-25</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543852-19197272.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543853/enpam-investe-sugli-studi-per-gli-iscritti-a-milano-il-primo-hub-a-prezzi-calmierati</loc>
  <lastmod>2026-09-25T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Enpam investe sugli studi per gli iscritti: a Milano il primo hub a prezzi calmierati</news:title>
   <news:publication_date>2026-09-25</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543853-studiomedico7.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543854/farmaceutica-prima-industria-italiana-per-intensita-di-innovazione</loc>
  <lastmod>2026-09-25T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Farmaceutica prima industria italiana per intensità di innovazione</news:title>
   <news:publication_date>2026-09-25</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543854-1645.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543760/biontech-gotistobart-allunga-la-sopravvivenza-nel-nsclc-squamoso-recidivato</loc>
  <lastmod>2026-09-25T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>BioNTech, gotistobart allunga la sopravvivenza nel NSCLC squamoso recidivato</news:title>
   <news:publication_date>2026-09-25</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543760-fcf886c1-ea6d-4a77-a284-fa178375c474.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543855/chirurgia-estetica-mori-dopo-tre-interventi-chieste-condanne-per-tre-medici</loc>
  <lastmod>2026-09-25T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Chirurgia estetica, morì dopo tre interventi: chieste condanne per tre medici</news:title>
   <news:publication_date>2026-09-25</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543855-anteprimearticolidottnet27.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543856/infezione-ospedaliera-da-acinetobacter-morto-dopo-l-intervento-risarcimento-da-480mila-euro</loc>
  <lastmod>2026-09-25T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Infezione ospedaliera da Acinetobacter, morto dopo l&#39;intervento: risarcimento da 480mila euro</news:title>
   <news:publication_date>2026-09-25</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543856-risarcimento.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543857/ferie-non-godute-nella-pa-cambia-la-monetizzazione-quando-scatta-l-indennita</loc>
  <lastmod>2026-09-25T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Ferie non godute nella Pa, cambia la monetizzazione: quando scatta l&#39;indennità</news:title>
   <news:publication_date>2026-09-25</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543857-anteprimearticolidottnet28.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543858/medici-ssn-anaao-troppo-fisco-stipendi-da-adeguare-all-europa</loc>
  <lastmod>2026-09-25T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Medici Ssn, Anaao: troppo fisco, stipendi da adeguare all&#39;Europa</news:title>
   <news:publication_date>2026-09-25</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543858-medici3.jpg</image:loc>
  </image:image>
 </url>
 <url>
  <loc>https://www.dottnet.it/articolo/32543859/responsabilita-medica-niente-manleva-se-la-richiesta-precede-la-polizza</loc>
  <lastmod>2026-09-25T00:00:00.000Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Dottnet</news:name>
    <news:language>it</news:language>
   </news:publication>
   <news:title>Responsabilità medica, niente manleva se la richiesta precede la polizza</news:title>
   <news:publication_date>2026-09-25</news:publication_date>
  </news:news>
  <image:image>
   <image:loc>https://content.dottnet.it/content/articolo/32543859-cassazione.png</image:loc>
  </image:image>
 </url>
</urlset>